{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T14:40:28Z","timestamp":1791297628319,"version":"4.1.0"},"reference-count":34,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2015,6,1]],"date-time":"2015-06-01T00:00:00Z","timestamp":1433116800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,6,1]],"date-time":"2015-06-01T00:00:00Z","timestamp":1433116800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","metabolismjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Metabolism"],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1016\/j.metabol.2015.03.004","type":"journal-article","created":{"date-parts":[[2015,3,14]],"date-time":"2015-03-14T01:32:14Z","timestamp":1426296734000},"page":"706-712","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"title":["Changes in visceral and subcutaneous fat mass in patients with pheochromocytoma"],"prefix":"10.1016","volume":"64","author":[{"given":"Takashi","family":"Okamura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuyo","family":"Nakajima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsurou","family":"Satoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koshi","family":"Hashimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Santosh","family":"Sapkota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eijiro","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuichi","family":"Okada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junya","family":"Fukuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuya","family":"Higuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshito","family":"Tsushima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masanobu","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.metabol.2015.03.004_bb0005","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1080\/10253890701395896","article-title":"Pheochromocytoma as a catecholamine producing tumor: implications for clinical practice","volume":"10","author":"Zelinka","year":"2007","journal-title":"Stress"},{"key":"10.1016\/j.metabol.2015.03.004_bb0010","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/S0140-6736(05)67139-5","article-title":"Phaeochromocytoma","volume":"366","author":"Lenders","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.metabol.2015.03.004_bb0015","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1210\/jc.2004-1398","article-title":"Year of diagnosis, features at presentation, and risk of recurrence in patients with pheochromocytoma or secreting paraganglioma","volume":"90","author":"Amar","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.metabol.2015.03.004_bb0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1196\/annals.1353.001","article-title":"An overview of pheochromocytoma: history, current concepts, vagaries, and diagnostic challenges","volume":"1073","author":"Manger","year":"2006","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.metabol.2015.03.004_bb0025","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1016\/j.amjhyper.2005.06.026","article-title":"The vagaries of pheochromocytomas","volume":"18","author":"Manger","year":"2005","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.metabol.2015.03.004_bb0030","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/j.1365-2796.2005.01504.x","article-title":"Long-term outcome of a large series of patients surgically treated for pheochromocytoma","volume":"258","author":"Khorram-Manesh","year":"2005","journal-title":"J Intern Med"},{"key":"10.1016\/j.metabol.2015.03.004_bb0035","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1097\/00000658-199906000-00001","article-title":"Clinical experience over 48years with pheochromocytoma","volume":"229","author":"Goldstein","year":"1999","journal-title":"Ann Surg"},{"key":"10.1016\/j.metabol.2015.03.004_bb0040","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/j.1365-2796.2009.02111.x","article-title":"SDH mutations in tumorigenesis and inherited endocrine tumours: lesson from the phaeochromocytoma-paraganglioma syndromes","volume":"266","author":"Pasini","year":"2009","journal-title":"J Intern Med"},{"key":"10.1016\/j.metabol.2015.03.004_bb0045","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1530\/eje.0.1500681","article-title":"Circumstances of discovery of phaeochromocytoma: a retrospective study of 41 consecutive patients","volume":"150","author":"Baguet","year":"2004","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.metabol.2015.03.004_bb0050","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1159\/000169145","article-title":"Insulin-requiring diabetes mellitus, hyperlipidemia, and anginal chest pains as prominent features of pheochromocytoma","volume":"17","author":"Rofougaran","year":"1997","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.metabol.2015.03.004_bb0055","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1136\/pgmj.68.799.371","article-title":"Lipid and lipoprotein metabolism in familial combined hyperlipidaemia during treatment of sporadic phaeochromocytoma: a case study","volume":"68","author":"Winocour","year":"1992","journal-title":"Postgrad Med J"},{"issue":"Suppl. 5","key":"10.1016\/j.metabol.2015.03.004_bb0060","first-page":"153","article-title":"Pheochromocytoma","volume":"70","author":"Tanabe","year":"2012","journal-title":"Nihon Rinsho"},{"key":"10.1016\/j.metabol.2015.03.004_bb0065","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1249\/MSS.0b013e3181f1bef3","article-title":"Catecholamine response to exercise in obese, overweight, and lean adolescent boys","volume":"43","author":"Jabbour","year":"2011","journal-title":"Med Sci Sports Exerc"},{"key":"10.1016\/j.metabol.2015.03.004_bb0070","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1210\/jc.2012-3625","article-title":"Changes in energy metabolism in pheochromocytoma","volume":"98","author":"Petr\u00e1k","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.metabol.2015.03.004_bb0075","doi-asserted-by":"crossref","first-page":"3280","DOI":"10.1210\/jc.2013-1353","article-title":"Subclinical hypothyroidism and indices for metabolic syndrome in Japanese women: one-year follow-up study","volume":"98","author":"Nakajima","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.metabol.2015.03.004_bb0080","doi-asserted-by":"crossref","first-page":"2676","DOI":"10.2337\/diacare.27.11.2676","article-title":"Does the metabolic syndrome improve identification of individuals at risk of type 2 diabetes and\/or cardiovascular disease?","volume":"27","author":"Stern","year":"2004","journal-title":"Diabetes Care"},{"key":"10.1016\/j.metabol.2015.03.004_bb0085","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1016\/j.clinbiochem.2009.05.018","article-title":"Hepatic insulin resistance, metabolic syndrome and cardiovascular disease","volume":"42","author":"Meshkani","year":"2009","journal-title":"Clin Biochem"},{"key":"10.1016\/j.metabol.2015.03.004_bb0090","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1111\/j.1476-5381.1996.tb15279.x","article-title":"In situ assessment of the role of the beta 1-, beta 2- and beta 3-adrenoceptors in the control of lipolysis and nutritive blood flow in human subcutaneous adipose tissue","volume":"117","author":"Barbe","year":"1996","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.metabol.2015.03.004_bb0095","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1172\/JCI117758","article-title":"A pathogenic role of visceral fat beta 3-adrenoceptors in obesity","volume":"95","author":"L\u00f6nnqvist","year":"1995","journal-title":"J Clin Invest"},{"key":"10.1016\/j.metabol.2015.03.004_bb0100","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.physbeh.2008.01.002","article-title":"Catecholamine-induced lipolysis in adipose tissue and skeletal muscle in obesity","volume":"94","author":"Jocken","year":"2008","journal-title":"Physiol Behav"},{"key":"10.1016\/j.metabol.2015.03.004_bb0105","first-page":"47","article-title":"The role of cyclic AMP in activation of hormone-sensitive lipase of adipose tissue","volume":"1","author":"Steinberg","year":"1972","journal-title":"Adv Cyclic Nucleotide Res"},{"key":"10.1016\/j.metabol.2015.03.004_bb0110","doi-asserted-by":"crossref","first-page":"3190","DOI":"10.2337\/diabetes.54.11.3190","article-title":"Adipocyte lipases and defect of lipolysis in human obesity","volume":"54","author":"Langin","year":"2005","journal-title":"Diabetes"},{"key":"10.1016\/j.metabol.2015.03.004_bb0120","doi-asserted-by":"crossref","first-page":"E1847","DOI":"10.1152\/ajpendo.00040.2007","article-title":"Comparative studies of the role of hormone-sensitive lipase and adipose triglyceride lipase in human fat cell lipolysis","volume":"292","author":"Ryd\u00e9n","year":"2007","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.metabol.2015.03.004_bb0125","doi-asserted-by":"crossref","first-page":"E1144","DOI":"10.1152\/ajpendo.2000.278.6.E1144","article-title":"Whole body and abdominal lipolytic sensitivity to epinephrine is suppressed in upper body obese women","volume":"278","author":"Horowitz","year":"2000","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.metabol.2015.03.004_bb0130","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1007\/BF00408482","article-title":"Catecholamine resistance in fat cells of women with upper-body obesity due to decreased expression of beta 2-adrenoceptors","volume":"37","author":"Reynisdottir","year":"1994","journal-title":"Diabetologia"},{"key":"10.1016\/j.metabol.2015.03.004_bb0135","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/S0022-2275(20)37246-1","article-title":"Variation in adrenergic regulation of lipolysis between omental and subcutaneous adipocytes from obese and non-obese men","volume":"38","author":"Hoffstedt","year":"1997","journal-title":"J Lipid Res"},{"key":"10.1016\/j.metabol.2015.03.004_bb0140","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/S0022-2275(20)37282-5","article-title":"Norepinephrine-induced lipolysis in rat fat cells from visceral and subcutaneous sites: role of hormone-sensitive lipase and lipid droplets","volume":"38","author":"Morimoto","year":"1997","journal-title":"J Lipid Res"},{"key":"10.1016\/j.metabol.2015.03.004_bb0145","first-page":"E948","article-title":"Effect of epinephrine on amino acid and energy metabolism in humans","volume":"258","author":"Matthews","year":"1990","journal-title":"Am J Physiol"},{"key":"10.1016\/j.metabol.2015.03.004_bb0150","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/0026-0495(86)90177-0","article-title":"Effect of epinephrine infusion and adrenergic blockade on glucose oxidation in conscious dogs","volume":"35","author":"Wolfe","year":"1986","journal-title":"Metabolism"},{"key":"10.1016\/j.metabol.2015.03.004_bb0155","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1097\/00003246-199310000-00018","article-title":"Effects of norepinephrine, epinephrine, and dopamine infusions on oxygen consumption in volunteers","volume":"21","author":"Ensinger","year":"1993","journal-title":"Crit Care Med"},{"key":"10.1016\/j.metabol.2015.03.004_bb0160","doi-asserted-by":"crossref","first-page":"E775","DOI":"10.1152\/ajpendo.00175.2003","article-title":"Effect of beta1- and beta2-adrenergic stimulation on energy expenditure, substrate oxidation, and UCP3 expression in humans","volume":"285","author":"Hoeks","year":"2003","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.metabol.2015.03.004_bb0165","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/0026-0495(94)90085-X","article-title":"The relationship of epinephrine excretion to serum lipid levels: the Normative Aging Study","volume":"43","author":"Ward","year":"1994","journal-title":"Metabolism"},{"key":"10.1016\/j.metabol.2015.03.004_bb0170","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.autneu.2011.10.006","article-title":"Association of plasma epinephrine level with insulin sensitivity in metabolically healthy but obese individuals","volume":"167","author":"Dai","year":"2012","journal-title":"Auton Neurosci"},{"key":"10.1016\/j.metabol.2015.03.004_bb0175","doi-asserted-by":"crossref","first-page":"e108","DOI":"10.1038\/nutd.2014.4","article-title":"Modulation of adipose tissue lipolysis and body weight by high-density lipoproteins in mice","volume":"4","author":"Wei","year":"2014","journal-title":"Nutr Diabetes"}],"container-title":["Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049515000785?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049515000785?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T04:05:47Z","timestamp":1758427547000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026049515000785"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6]]},"references-count":34,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015,6]]}},"alternative-id":["S0026049515000785"],"URL":"https:\/\/doi.org\/10.1016\/j.metabol.2015.03.004","relation":{},"ISSN":["0026-0495"],"issn-type":[{"value":"0026-0495","type":"print"}],"subject":[],"published":{"date-parts":[[2015,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Changes in visceral and subcutaneous fat mass in patients with pheochromocytoma","name":"articletitle","label":"Article Title"},{"value":"Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.metabol.2015.03.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}